
San Diego Startup's 'Molecular Glue' Begins Cancer Trial
A San Diego biotech company has started its first clinical trial of a groundbreaking treatment that tricks cancer cells into destroying themselves. The molecular glue technology has already attracted nearly $5 billion in deals from major pharmaceutical companies.

